In addition, we also determined the correlation of lncRNA TUG1 with long‐term prognosis in Ph− ALL patients, and the results exhibited that lncRNA TUG1 independently predicted worse DFS and OS, implying the role of lncRNA TUG1 as a potential biomarker in Ph− ALL management. This evidence concerns the gene TUG1 and acute lymphoblastic leukemia.